Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies

To conduct a systematic review of observational studies on the risk of acute myocardial infarction (AMI) with use of individual nonsteroidal anti‐inflammatory drugs (NSAIDs).

• Publication year

  2013

• Venue

  Pharmacoepidemiology and Drug Safety

• Publication date

  2013-04-25

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pds.3437PMID 23616423PMCID 3749466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014cited by this paper
• The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies.

  2013cited by this paper
• Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

  2011cited by this paper
• Stroke risk and NSAIDs: a systematic review of observational studies

  2011cited by this paper
• Duration of Treatment With Nonsteroidal Anti-Inflammatory Drugs and Impact on Risk of Death and Recurrent Myocardial Infarction in Patients With Prior Myocardial Infarction: A Nationwide Cohort Study

  2011cited by this paper
• Trends in Out-of-Hospital Deaths Due to Coronary Heart Disease in Sweden (1991 to 2006)

  2011cited by this paper
• Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta‐Analyses of Randomized Clinical Trials

  2011cited by this paper
• Use of non-steroidal antiinflammatory drugs and type-specific risk of acute coronary syndrome.

  2010cited by this paper
• Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals

  2010cited by this paper
• NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population

  2010cited by this paper
• Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation.

  2010cited by this paper
• Cardiovascular Risks of Nonsteroidal Antiinflammatory Drugs in Patients After Hospitalization for Serious Coronary Heart Disease

  2009cited by this paper
• The use of selective cyclooxygenase‐2 inhibitors and the risk of acute myocardial infarction in Saskatchewan, Canada

  2009cited by this paper
• The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs

  2008cited by this paper
• Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.

  2008cited by this paper
• Onset of acute myocardial infarction after use of non‐steroidal anti‐inflammatory drugs

  2008cited by this paper
• Immortal time bias in pharmaco-epidemiology.

  2008cited by this paper
• Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials

  2007cited by this paper
• Primer: administrative health databases in observational studies of drug effects—advantages and disadvantages

  2007cited by this paper
• Cyclooxygenase‐2 selectivity of non‐steroidal anti‐inflammatory drugs and the risk of myocardial infarction and cerebrovascular accident

  2007cited by this paper
• Cardiovascular Risk Associated With Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

  2006cited by this paper
• Use of First- and Second-Generation Cyclooxygenase-2–Selective Nonsteroidal Antiinflammatory Drugs and Risk of Acute Myocardial Infarction

  2006cited by this paper
• Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

  2006cited by this paper
• NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.

  2006cited by this paper
• Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors

  2006cited by this paper
• Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

  2006cited by this paper
• Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

  2006cited by this paper
• Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction.

  2006cited by this paper
• Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships.

  2006cited by this paper
• Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.

  2006cited by this paper
• Patients Exposed to Rofecoxib and Celecoxib Have Different Odds of Nonfatal Myocardial Infarction

  2005cited by this paper
• The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction

  2005cited by this paper
• Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

  2005cited by this paper
• Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.

  2005cited by this paper
• Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

  2005cited by this paper
• Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.

  2005cited by this paper
• Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population

  2005cited by this paper
• Nonsteroidal Antiinflammatory Drugs and the Risk of Myocardial Infarction in the General Population

  2004cited by this paper
• The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.

  2004cited by this paper
• Clinical Pharmacology of Platelet, Monocyte, and Vascular Cyclooxygenase Inhibition by Naproxen and Low-Dose Aspirin in Healthy Subjects

  2004cited by this paper
• Evaluating medication effects outside of clinical trials: new-user designs.

  2003cited by this paper
• Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly.

  2003cited by this paper
• COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease.

  2002cited by this paper
• Nonsteroidal anti-inflammatory drug use and acute myocardial infarction.

  2002cited by this paper
• Introduction aux modèles de régression

  2000cited by this paper
• [Introduction to regression models].

  2000cited by this paper
• Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.

  2000cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Exclusion bias and the false relationship of reserpine and breast cancer.

  1985cited by this paper

• Choosing a nonsteroidal anti-inflammatory drug for pain

  2025cites this paper
• Overall compilation of adverse effects of non-steroidal anti-inflammatory drugs: a hypothesis-free systematic investigation using a nationwide cohort study

  2025cites this paper
• Perioperative management of patients with coronary artery disease. Guidelines of the All-Russian Public Organization “Federation of Anaesthesiologists and Reanimatologists” (the 2nd revision)

  2024cites this paper
• New Evidence on Diclofenac: Implications for Cardiovascular Safety

  2024influential citation
• Периоперационное ведение пациентов с артериальной гипертензией. Методические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов»

  2024cites this paper
• NSAID: Current limits to prescription.

  2023cites this paper
• Differentiated approach to the treatment of musculoskeletal pain: higher doses of analgesics provide a better effect. A brief narrative review

  2023cites this paper
• NOVEMA® NIGHT (diphenhydramine + naproxen) in patients with pain and insomnia: results of a multicenter non-interventional observational study

  2023cites this paper
• Genicular Nerve Radiofrequency Ablation for the Treatment of Chronic Knee Joint Pain: A Real-world Cohort Study with Evaluation of Prognostic Factors.

  2023cites this paper
• Hip and Knee Osteoarthritis, Not Non-Steroidal Anti-Inflammatory Drugs, Are Linked to Cardiac Disease.

  2023cites this paper
• Impact of Lifestyle and Socioeconomic Position on the Association Between Non-steroidal Anti-inflammatory Drug Use and Major Adverse Cardiovascular Events: A Case-Crossover Study

  2023cites this paper
• High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases

  2022cites this paper
• Impact of lifestyle and socioeconomic position on use of non‐steroidal anti‐inflammatory drugs: A population‐based cohort study

  2022cites this paper
• Role of Real World Data in Pharmacoepidemiology Research: From Single Database Towards Global Collaboration

  2021cites this paper
• Peculiarities of non-steroidal anti-inflammatory drugs in the treatment of complicated caries in patients with concomitant somatic pathology

  2021cites this paper
• Safety considerations during prescription of non-steroidal anti-inflammatory drugs (NSAIDs), through a review of systematic reviews

  2021cites this paper
• Management of Osteoarthritis: Expert Opinion on NSAIDs

  2021cites this paper
• Database Analysis on the Relationships Between Nonsteroidal Anti-inflammatory Drug Treatment Variables and Incidence of Acute Myocardial Infarction in Japanese Patients with Osteoarthritis and Chronic Low Back Pain

  2021cites this paper
• Women With Osteoarthritis Are at Increased Risk of Ischemic Stroke: A Population-Based Cohort Study

  2021cites this paper
• Re-categorization of non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) according to clinical relevance: Abandoning the ´traditional NSAID´ terminology.

  2021cites this paper
• Acute anterior myocardial infarction during myopericarditis treatment in a very young adult

  2020cites this paper
• Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update

  2020cites this paper
• Safety of selective non-steroidal anti-inflammatory drugs: analysis of the last years data

  2020cites this paper
• Interdisciplinary approach to the management of patients with chronic gout

  2020cites this paper
• Spezielle Schmerztherapie bei rheumatischen Erkrankungen

  2020influential citation
• Perioperative management of patients with ventricular tachycardia

  2020cites this paper
• Controlling pain in dialysis care: a choice among undesirable options.

  2020cites this paper
• Perioperative management of patients with coronary artery disease

  2020cites this paper
• [Evaluation of a 12-week allopurinol-lowering therapy in combination with the non-steroidal anti-inflammatory drug meloxicam in patients with gout].

  2020cites this paper
• [Inflammation as a common pathogenic factor in coronary artery disease and depression].

  2020cites this paper
• Thermal Nerve Radiofrequency Ablation for the Nonsurgical Treatment of Knee Osteoarthritis: A Systematic Literature Review

  2020cites this paper
• Ethnic inequality in non-steroidal anti-inflammatory drug-associated harm in New Zealand: A national population-based cohort study.

  2020cites this paper
• Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations

  2020cites this paper
• Cardiovascular risk of non-steroidal anti-inflammatory drugs.

  2019cites this paper
• ETODOLAC, A WELL KNOWN AND ACTIVELY USED DRUG IN DIFFERENT COUNTRIES OF THE WORLD. WOULD IT BE TIME FOR US?

  2019cites this paper
• Pharmakotherapie bei Arthroseschmerzen

  2019cites this paper
• Нежелательные реакции со стороны сердечно-сосудистой системы при приеме нестероидных противовоспалительных препаратов, и пути их снижения Adverse Reactions of the Cardiovascular System when Taking Nonsteroidal Anti-inflammatory Drugs and Ways to Reduce Them АКТУАЛЬНЫЕ ВОПРОСЫ КЛИНИЧЕСКОЙ ФАРМАКОЛОГИ

  2019cites this paper
• Pharmacologically pertinent period of effect (PPPE)

  2019cites this paper
• [The efficacy and safety of naproxen in the treatment of nonspecific lumbalgia: the results of an open multi-center study (NEST)].

  2019cites this paper
• Duration of Treatment Effect Should Be Considered in the Design and Interpretation of Clinical Trials: Results of a Discrete Choice Experiment

  2019cites this paper
• Efficacy and safety of selective COX-2 inhibitors for pain management after third molar removal: a meta-analysis of randomized clinical trials

  2019cites this paper
• Progression of Korean Herbal Medicine and Conventional Medicine Administration for Cough in Patients with Myocardial Infraction Relapse Suspected of Developing Acute Respiratory Infection: Case Report

  2019cites this paper
• Inhibition of mPGES-1 as therapeutic strategy in inflammation and cancer

  2019cites this paper
• Non-aspirin NSAID use and ovarian cancer mortality.

  2018cites this paper
• Nonsteroidal anti-inflammatory drug choice and adverse outcomes in clopidogrel users: A retrospective cohort study

  2018cites this paper
• Adverse Effects and Drug

  2018influential citation
• Comparative cardiovascular safety of nonsteroidal anti‐inflammatory drugs in patients with hypertension: a population‐based cohort study

  2018cites this paper
• Predicting rapid analgesic onset of ibuprofen salts compared with ibuprofen acid: Tlag, Tlow, Tmed, and a novel parameter, TCmaxRef

  2018cites this paper
• Risk of acute myocardial infarction with real‐world NSAIDs depends on dose and timing of exposure

  2018cites this paper
• Celecoxib use and circulating oxylipins in a colon polyp prevention trial

  2018cites this paper
• Commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs.

  2018cites this paper
• The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults

  2018cites this paper
• Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample

  2018cites this paper
• Non-steroidal anti-inflammatory drugs and the risk of out-of-hospital cardiac arrest: a case–control study

  2018cites this paper
• Risk of ischemic stroke and the use of individual non-steroidal anti-inflammatory drugs: A multi-country European database study within the SOS Project

  2018cites this paper
• A narrative review of the cardiovascular risks associated with concomitant aspirin and NSAID use

  2018cites this paper
• Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project

  2018cites this paper
• Pharmacological treatment of knee osteoarthritis: Special considerations of the new German guideline

  2018cites this paper
• Pharmacological and nutritional support for the function of the musculoskeletal system of elite athletes

  2018cites this paper
• Pharmakotherapie bei Arthroseschmerzen

  2018cites this paper
• Nonsteroid Anti-Inflammatory Drugs in Sports Medicine: Effectiveness and Risks

  2018cites this paper
• CLINICAL EPIDEMIOLOGY OF VACCINES AND VACCINE-PREVENTABLE DISEASES USING ADMINISTRATIVE HEALTHCARE DATA

  2018cites this paper
• Clinical efficacy of resveratrol as an adjuvant with meloxican in the treatment of knee osteoarthritis patients: A double-blind, randomised, placebo-controlled trial

  2018cites this paper
• Prise en soins de la douleur en EHPAD

  2018cites this paper
• Pharmacotherapy of back and joint pain in general practitioner's office

  2018cites this paper
• Adverse Effects and Drug Interactions of the Non‐Steroidal Anti‐Inflammatory Drugs

  2017cites this paper
• Patients coronariens opérés en chirurgie non cardiaque : quel parcours de soins ?

  2017cites this paper
• Causal Inference Using Variation in Treatment over Time

  2017cites this paper
• Diverging Conclusions from the Same Meta-Analysis in Drug Safety: Source of Data (Primary Versus Secondary) Takes a Toll

  2017cites this paper
• Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case–Control Study

  2017cites this paper
• Meloxicam and risk of myocardial infarction: a population-based nested case–control study

  2017cites this paper
• Influence of aspirin and non-aspirin NSAID use on ovarian and endometrial cancer: Summary of epidemiologic evidence of cancer risk and prognosis.

  2017cites this paper
• Alleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory Drugs

  2017cites this paper
• Mechanical Interventions In Soft Tissue Repair

  2017cites this paper
• The Trend-in-trend Research Design for Causal Inference

  2017cites this paper
• Может ли амтолметил гуацил пригодиться в хирургической практике

  2017cites this paper
• ANTIPLATELET EFFECTS OF SOME CYCLOOXYGENASE-2 INHIBITORS IN EXPERIMENTAL HYPERCHOLESTEROLEMIA IN RABBITS

  2017cites this paper
• Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study

  2017cites this paper
• Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data

  2017cites this paper
• Impact of non-steroidal anti-inflammatory drugs on cardiovascular risk: Is it the same in osteoarthritis and rheumatoid arthritis?

  2017cites this paper
• University of Southern Denmark Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib

  2017influential citation
• Consumer knowledge about over‐the‐counter NSAIDs: they don't know what they don't know

  2017cites this paper
• Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review

  2016cites this paper
• Effects of Non-Steroidal Anti-Inflammatory Drugs on the Gastrointestinal and Cardiovascular System

  2016cites this paper
• Cardiovascular Risk Associated with the Use of Non Steroidal Anti-Inflammatory Drugs, Cases and Controls Study in a Health Care Area in Spain

  2016cites this paper
• Adverse Effects of Nonsteroidal Anti-inflammatory Drugs on the Cardiovascular System

  2016cites this paper
• Long-term strong opioid use in chronic noncancer pain patients in primary care settings

  2016cites this paper
• Safety and efficacy of low doses of diclofenac on acute pain in the emergency setting.

  2016cites this paper
• Randomised trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib

  2016influential citation
• DGRh-Empfehlungen zur Implementierung aktueller Sicherheitsaspekte in die NSAR-Therapie muskuloskelettaler Schmerzen

  2016cites this paper
• Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT)

  2016influential citation
• The Coxib case: Are EP receptors really guilty?

  2016cites this paper
• Acute myocardial infarction with oral nonsteroidal anti-inflammatory drugs in real-world use

  2016cites this paper
• NSAIDs diclofenac, indomethacin, and meloxicam highly upregulate expression of ICAM-1 and COX-2 induced by X-irradiation in human endothelial cells.

  2016cites this paper
• Use of Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Relation to Cardiovascular Events. A Systematic Pharmacoepidemiological Review.

  2016cites this paper
• Cardiovascular adverse events by non-steroidal anti-inflammatory drugs: when the benefits outweigh the risks

  2016influential citation
• [Improvement of the efficacy and safety of the treatment of patients with low back pain].

  2016cites this paper
• [The problem of cardiac safety of nonsteroidal anti-inflammatory drugs].

  2016cites this paper
• Non-steroidal anti-inflammatory drugs and risk of cerebrovascular events in patients with osteoarthritis: a nested case–control study

  2016cites this paper
• Evidence Synthesis and Meta-Analysis for Drug Safety

  2016cites this paper